Progenics Pharmaceuticals (NASDAQ:PGNX) CEO Interview


Progenics Pharmaceuticals
(NASDAQ:PGNX)
CEO: Mark Baker

p>This interview has expired.
Click here to find stocks, with exciting stories, and management committed to maximizing shareholder value.

TEST